Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases
source: pixabay.com

Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases

  For many families, when their child is born with developmental delays, there may be weeks, months, or even years that go by without a diagnosis. During this time, parents…

Continue Reading Genome Sequencing Offers Promise for Children with Rare Developmental Delays and Other Genetic Rare Diseases
Experimental Treatment for Charcot-Marie-Tooth Disease Gets FDA Fast Track Designation
annca / Pixabay

Experimental Treatment for Charcot-Marie-Tooth Disease Gets FDA Fast Track Designation

According to a story from Digital Journal, the biopharmaceutical company Acceleron Pharma, Inc., recently announced that its investigational drug candidate ACE-083 was granted Fast Track designation from the US Food…

Continue Reading Experimental Treatment for Charcot-Marie-Tooth Disease Gets FDA Fast Track Designation
Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment
mwooten / Pixabay

Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment

According to a story from BioPortfolio, Celgene Corporation and bluebird bio, Inc., have recently announced that enrollment for a pivotal Phase 2 study testing an experimental therapy for relapsed/refractory multiple…

Continue Reading Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment
ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis
Tabeajaichhalt / Pixabay

ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis

According to a story from Buzzfeed News, Stephen Hillenburg, the creator of the smash hit children's cartoon SpongeBob SquarePants has passed away at age 57. Last year, Hillenburg had revealed…

Continue Reading ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis
Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins
qimono / Pixabay

Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins

According to a story from globenewswire.com, the biopharmaceutical company PhaseBio Pharmaceuticals has recently announced that the first patient has been dosed in a Phase 2b clinical trial of the company's…

Continue Reading Clinical Trial Testing Experimental Treatment for Pulmonary Arterial Hypertension Begins
Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
Free-Photos / Pixabay

Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis

According to a story from pm360online.com, the drug developer Novartis has recently announced that the company's gene therapy Luxturna has gained approval in the EU as a treatment for Leber's…

Continue Reading Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis